Wealth Group Ltd Acquires Shares of 1,721 UnitedHealth Group Incorporated (NYSE:UNH)

Wealth Group Ltd bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,721 shares of the healthcare conglomerate’s stock, valued at approximately $879,000.

Several other institutional investors have also recently made changes to their positions in the stock. Little House Capital LLC raised its position in shares of UnitedHealth Group by 15.4% in the third quarter. Little House Capital LLC now owns 8,503 shares of the healthcare conglomerate’s stock worth $4,287,000 after buying an additional 1,133 shares in the last quarter. Octavia Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 9.0% in the third quarter. Octavia Wealth Advisors LLC now owns 837 shares of the healthcare conglomerate’s stock worth $422,000 after buying an additional 69 shares in the last quarter. Blue Chip Partners LLC raised its position in shares of UnitedHealth Group by 2.2% in the third quarter. Blue Chip Partners LLC now owns 51,102 shares of the healthcare conglomerate’s stock worth $25,765,000 after buying an additional 1,107 shares in the last quarter. Red Cedar Investment Management LLC raised its position in shares of UnitedHealth Group by 0.9% in the third quarter. Red Cedar Investment Management LLC now owns 6,267 shares of the healthcare conglomerate’s stock worth $3,160,000 after buying an additional 58 shares in the last quarter. Finally, Wallington Asset Management LLC raised its position in UnitedHealth Group by 0.5% during the third quarter. Wallington Asset Management LLC now owns 34,769 shares of the healthcare conglomerate’s stock valued at $17,530,000 after purchasing an additional 185 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $3.62 during midday trading on Wednesday, hitting $517.50. 2,981,164 shares of the stock traded hands, compared to its average volume of 4,275,279. The firm has a 50-day moving average of $483.69 and a two-hundred day moving average of $511.41. The firm has a market capitalization of $476.30 billion, a P/E ratio of 31.63, a PEG ratio of 1.48 and a beta of 0.55. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.26 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.45%. UnitedHealth Group’s payout ratio is presently 45.97%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on UNH shares. Barclays raised their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Morgan Stanley lowered their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Finally, Stephens reaffirmed an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Three analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $570.05.

Check Out Our Latest Research Report on UNH

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.